Mediclinic International

MDC: 403.80 +8.50 (+2.15%) delayed: 13 Dec 2019, 18:45

Trade now

Mediclinic International Fundamentals

Share Price Information

Name Mediclinic International
Epic MDC
Sector Health Care Providers
ISIN GB00B8HX8Z88
Activites Mediclinic International plc (formerly Al Noor Hospitals Group) is an international private healthcare services group, established in South Africa in 1983, with current operating divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, an LSE-listed and UK-based private healthcare group. As at 31 March 2019, Mediclinic comprised 77 hospitals, five sub-acute hospitals, 12 day case clinics and 21 outpatient clinics. Hirslanden operated 18 hospitals, two day case clinics and three outpatient clinics in Switzerland with more than 1 800 inpatient beds; Mediclinic Southern Africa operated 49 hospitals, five sub-acute hospitals and eight day case clinics across South Africa and three hospitals in Namibia with more than 8 500 inpatient beds; and Mediclinic Middle East operated seven hospitals, two day case clinics and 18 outpatient clinics with more than 900 inpatient beds in the United Arab Emirates.
Index FTSE 250

Key numbers

Latest Share price (p) 403.80 Net gearing (%) 45.07
Market capitalisation (£m) 2,837.65 Gross gearing (%) 49.19
Shares in issue (m) 737.24 Debt ratio 44.09
P/E ratio -18.78 Debt-to-equity ratio 0.82
Total dividends per share (p) 7.90 Assets / equity ratio 1.97
Dividend yield (%) 2.05 Price to book value 0.87
Dividend cover 0.00 ROCE (%) -2.35
Earning per share (p) -20.50 EPS growth (%) 69.27
52-week high / low (p) 410.30 / 288.30 DPS growth (%) 0.00

Results at a glance

Date Type Turnover (£m) Profit (£m) Basic EPS Currency
31 Mar 2019 Full Year 2,932 -130 -20.50 GBP
31 Mar 2018 Full Year 2,870 -474 -66.70 GBP
31 Mar 2017 Full Year 2,749 243 31.00 GBP

Dividend history

Period Ex-date Pay-date Net dividend Currency Total for year
H1 Dividend 05 Dec 2019 17 Dec 2019 3.20 GBX 0.00
H2 Dividend 13 Jun 2019 29 Jul 2019 4.70 GBX 7.90
H1 Dividend 06 Dec 2018 18 Dec 2018 3.20 GBX 0.00
H2 Dividend 14 Jun 2018 30 Jul 2018 4.70 GBX 7.90
H1 Dividend 07 Dec 2017 18 Dec 2017 3.20 GBX 0.00
H2 Dividend 22 Jun 2017 31 Jul 2017 4.70 GBX 7.90
H1 Dividend 24 Nov 2016 12 Dec 2016 3.20 GBX 0.00
H2 Dividend 16 Jun 2016 25 Jul 2016 5.24 GBX 7.00
H1 Dividend 03 Sep 2015 05 Oct 2015 4.10 GBX 0.00
H2 Dividend 16 Apr 2015 15 May 2015 9.00 GBX 12.70

Contact details

Company name Mediclinic International
Address 1st Floor, 40 Dukes Place, London EC3A 7NH.
Telephone +44 (0)20 3786 8180
Website http://www.mediclinic.com/

Advisors

Company's broker Morgan Stanley Securities
Company's joint broker n/a
NOMAD Morgan Stanley Securities
Registrar Link Asset Services
Auditors PricewaterhouseCoopers LLP
Solicitors Slaughter & May

Directors

Appointed Director Position
01 Jun 2018 Dr Carel Aron van der Merwe Chief Executive Officer
01 Aug 2016 Petrus Jurgens Myburgh Chief Financial Officer
07 Apr 2016 Petrus Johannes Uys Non-Executive Alt Director
15 Feb 2016 Dr Edwin De La Harpe Hertzog Non-Executive Chairman
24 Jul 2019 Thomas Daniel Singer Non-Executive Director
15 Feb 2016 Trevor David Petersen Non-Executive Director
25 Jul 2018 Dr Anja Klara Oswald Non-Executive Director
15 Feb 2016 Daniel Petrus Meintjes Non-Executive Director
05 Jun 2013 Seamus Declan Keating Non-Executive Director
03 Oct 2017 Dr Felicity Ann Hope Harvey Non-Executive Director
15 Feb 2016 James Alan Grieve Non-Executive Director
15 Feb 2016 Jan Jonathan Durand Non-Executive Director
01 Nov 2017 Dr Muhadditha Yahya Al Hashimi Non-Executive Director

Company financials

Assets (£m) 2019 2018 2017
Reporting date 31 Mar 2019 31 Mar 2018 31 Mar 2017
Tangible assets 3,524 3,590 3,703
Intangible asssets and goodwill 1,587 1,406 2,156
Investments and other non-current assets 226 386 494
Total non-current assets 5,337 5,382 6,353
Inventory / work in progress 88 90 90
Trade and other receivables 732 607 591
Cash and equivalents 265 261 361
Other current assets and asset held for resale 6 3 27
Total of all assets 6,428 6,343 7,422
Liabilities (£m) 2019 2018 2017
Short term liabilities 586 525 590
Long term liabilities 2,576 2,445 2,668
Other liabilites / pension etc 0 0 0
Total of all liabilities 3,162 2,970 3,258
Net assets (£m) 2019 2018 2017
Net assets 3,266 3,373 4,164
Equity (£m) 2019 2018 2017
Share capital 74 74 74
Minority interests 115 87 78
Retained earnings 4,769 5,057 5,525
Share premium account 690 690 690
Other equity -2,382 -2,535 -2,203
Total equity 3,266 3,373 4,164
Cash Flow (£m) 2019 2018 2017
Cash from operating activities 344 345 394
Cashflow before financing 46 26 176
Increase / decrease in Cash 12 -82 7
Income (£m) 2019 2018 2017
Turnover 2,932 2,870 2,749
Cost of sales 0 1,773 1,696
Gross profit 0 1,097 1,053
Operating profit 81 -288 362
Pre-tax profit -137 -479 307
Profit / loss for the year -130 -474 243